1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with glycine in 7 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (glycine) | Trials (glycine) | Recent Studies (post-2010) (glycine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 35,163 | 756 | 8,415 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | glycine (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 1.4852 | |
| Sodium- and chloride-dependent glycine transporter 1 | Homo sapiens (human) | 106 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.3253 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.3253 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.3253 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.3253 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.3253 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.3253 | |
| Sodium- and chloride-dependent glycine transporter 2 | Homo sapiens (human) | 128 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faden, AI; Tzendzalian, PA | 1 |
| Harpel, PC; Knudsen, BS; Nachman, RL | 1 |
| Fischereder, M; Nath, KA; Trick, W | 1 |
| Aoshiba, K; Kondo, M; Nagai, A; Nakata, J; Tagaya, E; Tamaoki, J; Yamawaki, I | 1 |
| Chatterjee, SS; Kondratskaya, EL; Krishtal, OA; Lishko, PV | 1 |
| Chatterjee, SS; Kondratskaya, EL; Krishtal, OA | 1 |
| Dangerfield, J; Nourshargh, S; Voisin, MB; Wang, S; Young, RE | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and glycine
| Article | Year |
|---|---|
Therapeutic strategies in the prevention of acute renal failure.
Topics: Acute Kidney Injury; Adenosine Triphosphate; Alanine; Animals; Atrial Natriuretic Factor; Calcium Channel Blockers; Endothelins; Free Radical Scavengers; Glycine; Humans; Misoprostol; Nitric Oxide; Platelet Activating Factor | 1994 |
6 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and glycine
| Article | Year |
|---|---|
Platelet-activating factor antagonists limit glycine changes and behavioral deficits after brain trauma.
Topics: Animals; Azepines; Behavior, Animal; Body Water; Brain; Brain Injuries; Cations; Dialysis; Diterpenes; Ginkgolides; Glycine; Lactones; Male; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Triazoles | 1992 |
Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells.
Topics: Animals; Cattle; Cells, Cultured; Electrophoresis, Polyacrylamide Gel; Extracellular Matrix; Glycine; Melanoma; Molecular Weight; Muscle, Smooth; Platelet Activating Factor; Thrombin; Time Factors; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1987 |
Effect of azelastine on platelet-activating factor-induced microvascular leakage in rat airways.
Topics: Animals; Anti-Allergic Agents; Bronchoalveolar Lavage Fluid; Capillary Permeability; Cell Movement; Cyclophosphamide; Dose-Response Relationship, Drug; Glycine; Leukocyte Elastase; Male; Microcirculation; Neutrophils; Phthalazines; Platelet Activating Factor; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Sulfonamides | 1999 |
BN52021, a platelet activating factor antagonist, is a selective blocker of glycine-gated chloride channel.
Topics: Animals; Binding, Competitive; Chloride Channels; Diterpenes; Ginkgolides; Glycine; Hippocampus; In Vitro Techniques; Ion Channel Gating; Lactones; Platelet Activating Factor; Rats; Rats, Wistar; Receptors, Glycine; Strychnine | 2002 |
Structure-activity studies with Ginkgo biloba extract constituents as receptor-gated chloride channel blockers and modulators.
Topics: Animals; Animals, Newborn; Cerebellum; Chloride Channels; Cyclopentanes; Diterpenes; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Electric Conductivity; Furans; gamma-Aminobutyric Acid; Ginkgo biloba; Ginkgolides; Glycine; Hippocampus; In Vitro Techniques; Inhibitory Concentration 50; Lactones; Neurons; Patch-Clamp Techniques; Plant Extracts; Platelet Activating Factor; Pyrans; Rats; Rats, Wistar; Structure-Activity Relationship | 2003 |
Role of neutrophil elastase in LTB4-induced neutrophil transmigration in vivo assessed with a specific inhibitor and neutrophil elastase deficient mice.
Topics: Animals; Basement Membrane; Bone Marrow Cells; Cell Movement; Chemotaxis, Leukocyte; Enzyme Inhibitors; Glycine; Leukocyte Elastase; Leukotriene B4; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Confocal; Neutrophils; Platelet Activating Factor; Sulfonamides; Venules | 2007 |